News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
375,705 Results
Type
Article (25714)
Company Profile (70)
Press Release (349921)
Section
Business (104183)
Career Advice (446)
Deals (16862)
Drug Delivery (47)
Drug Development (47512)
Employer Resources (47)
FDA (12228)
Job Trends (8418)
News (185724)
Policy (19386)
Tag
Academia (1730)
Alliances (26597)
Alzheimer's disease (731)
Approvals (12217)
Artificial intelligence (99)
Bankruptcy (136)
Best Places to Work (6862)
Breast cancer (131)
Cancer (879)
Cardiovascular disease (78)
Career advice (407)
Cell therapy (142)
Clinical research (39657)
Collaboration (265)
Compensation (62)
COVID-19 (1456)
C-suite (64)
Data (954)
Diabetes (108)
Diagnostics (3384)
Earnings (36055)
Events (50738)
Executive appointments (247)
FDA (12755)
Funding (227)
Gene therapy (77)
GLP-1 (328)
Government (2996)
Healthcare (12137)
Infectious disease (1507)
Inflammatory bowel disease (67)
IPO (6981)
Job creations (1836)
Job search strategy (377)
Layoffs (153)
Legal (3616)
Lung cancer (146)
Lymphoma (63)
Manufacturing (74)
Medical device (12736)
Medtech (12739)
Mergers & acquisitions (9992)
Metabolic disorders (286)
Neuroscience (926)
NextGen Class of 2024 (3926)
Non-profit (2815)
Northern California (873)
Obesity (165)
Opinion (63)
Parkinson's disease (56)
Patents (60)
People (34201)
Phase I (11350)
Phase II (17175)
Phase III (14101)
Pipeline (291)
Postmarket research (1667)
Preclinical (3540)
Radiopharmaceuticals (156)
Rare diseases (120)
Real estate (2838)
Regulatory (13770)
Research institute (1598)
Southern California (756)
Startups (2116)
United States (8458)
Vaccines (297)
Weight loss (114)
Date
Last 7 days (335)
Last 30 days (1305)
Last 365 days (19801)
2024 (19718)
2023 (22740)
2022 (30685)
2021 (32988)
2020 (32198)
2019 (28416)
2018 (21811)
2017 (18906)
2016 (18111)
2015 (21194)
2014 (16023)
2013 (13241)
2012 (14349)
2011 (14622)
2010 (13181)
Location
Africa (353)
Arizona (92)
Asia (24146)
Australia (3817)
California (1928)
Canada (877)
China (215)
Colorado (108)
Connecticut (114)
Delaware (66)
Europe (47093)
Florida (329)
Georgia (84)
Illinois (260)
Indiana (157)
Japan (56)
Kansas (67)
Maryland (455)
Massachusetts (1403)
Michigan (77)
Minnesota (194)
New Jersey (711)
New York (592)
North Carolina (422)
Northern California (873)
Ohio (92)
Pennsylvania (570)
South America (518)
Southern California (756)
Texas (327)
Utah (63)
Washington State (159)
375,705 Results for "lepu medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Keymed and Lepu Biopharma Jointly Announce Global Exclusive Licence Agreement with AstraZeneca for CMG901
Keymed Biosciences Inc., and Lepu Biopharma Co., Ltd, jointly announce a global exclusive licence agreement with AstraZeneca for CMG901, a potential first-in-class Claudin 18.2 antibody drug conjugate.
February 23, 2023
·
3 min read
Press Releases
Tenon Medical(R) Regains Full Compliance with Nasdaq Continued Listing Requirements
October 28, 2024
·
3 min read
News
Tenon Medical(R) Announces Issuance of Three U.S. Patents
October 18, 2024
·
4 min read
Press Releases
Neo Medical’s Spine Care Platform Fully Approved Under EU Medical Device Regulation Directive
December 2, 2024
·
4 min read
Anti-PD-1 monoclonal antibody Puyouheng™ (HX-008, Pucotenlimab injection) Co-developed by LEPU BIOPHARMA and HANX BIOPHARMACEUTICALS was approved for marketing in China by NMPA
PuyouhengTM (HX-008, pucotenlimab injection), was conditionally approved by the National Medical Products Administration (NMPA) for marketing in China to treat patients with unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) advanced solid tumors, specifically.
July 25, 2022
·
5 min read
Business
Inspirna Announces Appointment of Karim Benhadji, M.D., as Chief Medical Officer and Retirement of Robert Wasserman, M.D.
Inspirna, Inc. announced today the appointment of Karim Benhadji, M.D., as Chief Medical Officer, effective May 1, 2024.
May 21, 2024
·
4 min read
Press Releases
Neusoft Medical Systems Showcases AI-powered Medical Imaging Solutions at RSNA 2024
December 3, 2024
·
2 min read
Press Releases
Esteemed Harvard Medical School Professor Dr. Michael Gibson Appointed Chief Medical Advisor at Lexaria Bioscience
December 17, 2024
·
5 min read
Press Releases
Adagio Medical Announces Appointment of Accomplished Medical Device Leader Todd Usen as Chief Executive Officer and Director
December 16, 2024
·
5 min read
Press Releases
AVITA Medical to Host Investor Webinar Briefing
November 8, 2024
·
2 min read
1 of 37,571
Next
